Digesting all the options: Laboratory testing for celiac disease

References

• Husby S, Koletzko S, Korponay-Szabo IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012;54:136–60
   PubMed Web of Science ®Google Scholar
• Fasano A, Catassi C. Clinical practice. Celiac disease. N Engl J Med 2012;367:2419–26
   PubMed Web of Science ®Google Scholar
• Green PH, Cellier C. Celiac disease. N Engl J Med 2007;357:1731–43
   PubMed Web of Science ®Google Scholar
• Rubio-Tapia A, Van Dyke CT, Lahr BD, et al. Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol 2008;6:983–7
   PubMed Web of Science ®Google Scholar
• Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D. Cancers and immune related diseases associated with Down's syndrome: a record linkage study. Arch Dis Child 2004;89:1014–17
   PubMed Web of Science ®Google Scholar
• Wouters J, Weijerman ME, van Furth AM, et al. Prospective human leukocyte antigen, endomysium immunoglobulin A antibodies, and transglutaminase antibodies testing for celiac disease in children with Down syndrome. J Pediatr 2009;154:239–42
   PubMed Web of Science ®Google Scholar
• Bonamico M, Pasquino AM, Mariani P, et al. Prevalence and clinical picture of celiac disease in Turner syndrome. J Clin Endocrinol Metab 2002;87:5495–8
   PubMed Web of Science ®Google Scholar
• Frost AR, Band MM, Conway GS. Serological screening for coeliac disease in adults with Turner's syndrome: prevalence and clinical significance of endomysium antibody positivity. Eur J Endocrinol 2009;160:675–9
   PubMed Web of Science ®Google Scholar
• Lenhardt A, Plebani A, Marchetti F, et al. Role of human-tissue transglutaminase IgG and anti-gliadin IgG antibodies in the diagnosis of coeliac disease in patients with selective immunoglobulin A deficiency. Dig Liver Dis 2004;36:730–4
   PubMedGoogle Scholar
• Hansen D, Brock-Jacobsen B, Lund E, et al. Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years' follow-up. Diabetes Care 2006;29:2452–6
   PubMed Web of Science ®Google Scholar
• Salardi S, Volta U, Zucchini S, et al. Prevalence of celiac disease in children with type 1 diabetes mellitus increased in the mid-1990 s: an 18-year longitudinal study based on anti-endomysial antibodies. J Pediatr Gastroenterol Nutr 2008;46:612–14
   PubMed Web of Science ®Google Scholar
• Volta U, Tovoli F, Caio G. Clinical and immunological features of celiac disease in patients with Type 1 diabetes mellitus. Expert Rev Gastroenterol Hepatol 2011;5:479–87
   PubMed Web of Science ®Google Scholar
• Shan L, Molberg O, Parrot I, et al. Structural basis for gluten intolerance in celiac sprue. Science 2002;297:2275–9
   PubMed Web of Science ®Google Scholar
• Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol 2005;2:416–22
   PubMedGoogle Scholar
• Dorum S, Arntzen MO, Qiao SW, et al. The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes. PLoS One 2010;5:e14056
   PubMed Web of Science ®Google Scholar
• Dorum S, Qiao SW, Sollid LM, Fleckenstein B. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease. J Proteome Res 2009;8:1748–55
   PubMed Web of Science ®Google Scholar
• Sollid LM, Jabri B. Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders. Curr Opin Immunol 2011;23:732–8
   Google Scholar
• Siegel M, Strnad P, Watts RE, et al. Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS One 2008;3:e1861
   PubMed Web of Science ®Google Scholar
• van de Wal Y, Kooy Y, van Veelen P, et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998;161:1585–8
   PubMed Web of Science ®Google Scholar
• Qiao SW, Sollid LM, Blumberg RS. Antigen presentation in celiac disease. Curr Opin Immunol 2009;21:111–17
   PubMed Web of Science ®Google Scholar
• Sollid LM, Molberg O, McAdam S, Lundin KE. Autoantibodies in coeliac disease: tissue transglutaminase–guilt by association? Gut 1997;41:851–2
   PubMed Web of Science ®Google Scholar
• Karell K, Louka AS, Moodie SJ, et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003;64:469–77
   PubMed Web of Science ®Google Scholar
• Rubio-Tapia A, Hill ID, Kelly CP, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013;108:656–76; quiz 77
   PubMed Web of Science ®Google Scholar
• Oxentenko AS, Grisolano SW, Murray JA, et al. The insensitivity of endoscopic markers in celiac disease. Am J Gastroenterol 2002;97:933–8
   PubMed Web of Science ®Google Scholar
• Marsh MN, Crowe PT. Morphology of the mucosal lesion in gluten sensitivity. Bailliere's Clin Gastroenterol 1995;9:273–93
   PubMed Web of Science ®Google Scholar
• Fry L, Seah PP, McMinn RM, Hoffbrand AV. Lymphocytic infiltration of epithelium in diagnosis of gluten-sensitive enteropathy. Br Med J 1972;3:371–4
   PubMed Web of Science ®Google Scholar
• Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue'). Gastroenterology 1992;102:330–54
   PubMed Web of Science ®Google Scholar
• Gonzalez S, Gupta A, Cheng J, et al. Prospective study of the role of duodenal bulb biopsies in the diagnosis of celiac disease. Gastrointest Endosc 2010;72:758–65
   PubMed Web of Science ®Google Scholar
• Lebwohl B, Kapel RC, Neugut AI, et al. Adherence to biopsy guidelines increases celiac disease diagnosis. Gastrointest Endosc 2011;74:103–9
   PubMed Web of Science ®Google Scholar
• Pais WP, Duerksen DR, Pettigrew NM, Bernstein CN. How many duodenal biopsy specimens are required to make a diagnosis of celiac disease? Gastrointest Endosc 2008;67:1082–7
   PubMed Web of Science ®Google Scholar
• Ravelli A, Villanacci V, Monfredini C, et al. How patchy is patchy villous atrophy?: distribution pattern of histological lesions in the duodenum of children with celiac disease. Am J Gastroenterol 2010;105:2103–10
   PubMed Web of Science ®Google Scholar
• Valitutti F, Di Nardo G, Barbato M, et al. Mapping histologic patchiness of celiac disease by push enteroscopy. Gastrointest Endosc 2014;79:95–100
   PubMed Web of Science ®Google Scholar
• Weir DC, Glickman JN, Roiff T, et al. Variability of histopathological changes in childhood celiac disease. Am J Gastroenterol 2010;105:207–12
   PubMed Web of Science ®Google Scholar
• Bonamico M, Thanasi E, Mariani P, et al. Duodenal bulb biopsies in celiac disease: a multicenter study. J Pediatr Gastroenterol Nutr 2008;47:618–22
   PubMed Web of Science ®Google Scholar
• Evans KE, Aziz I, Cross SS, et al. A prospective study of duodenal bulb biopsy in newly diagnosed and established adult celiac disease. Am J Gastroenterol 2011;106:1837–42
   PubMed Web of Science ®Google Scholar
• Pai RK. A practical approach to small bowel biopsy interpretation: celiac disease and its mimics. Semin Diagn Pathol 2014;31:124–36
   PubMed Web of Science ®Google Scholar
• Shah VH, Rotterdam H, Kotler DP, et al. All that scallops is not celiac disease. Gastrointest Endosc 2000;51:717–20
   PubMed Web of Science ®Google Scholar
• Walker MM, Murray JA, Ronkainen J, et al. Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology 2010;139:112–19
   PubMed Web of Science ®Google Scholar
• McNeish AS, Harms HK, Rey J, et al. The diagnosis of coeliac disease. A commentary on the current practices of members of the European Society for Paediatric Gastroenterology and Nutrition (ESPGAN). Arch Dis Child 1979;54:783–6
   PubMed Web of Science ®Google Scholar
• Chorzelski TP, Beutner EH, Sulej J, et al. IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease. Br J Dermatol 1984;111:395–402
   PubMed Web of Science ®Google Scholar
• Picarelli A, Di Tola M, Sabbatella L, et al. 31–43 amino acid sequence of the alpha-gliadin induces anti-endomysial antibody production during in vitro challenge. Scand J Gastroenterol 1999;34:1099–102
   PubMed Web of Science ®Google Scholar
• Ladinser B, Rossipal E, Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut 1994;35:776–8
   PubMed Web of Science ®Google Scholar
• Volta U, Molinaro N, de Franceschi L, et al. IgA anti-endomysial antibodies on human umbilical cord tissue for celiac disease screening. Save both money and monkeys. Dig Dis Sci 1995;40:1902–5
   PubMed Web of Science ®Google Scholar
• Amara W, Husebekk A. Improved method for serological testing in celiac disease–IgA anti-endomysium antibody test: a comparison between monkey oesophagus and human umbilical cord as substrate in indirect immunofluorescence test. Scand J Clin Lab Invest 1998;58:547–54
   PubMed Web of Science ®Google Scholar
• Carroccio A, Cavataio F, Iacono G, et al. IgA antiendomysial antibodies on the umbilical cord in diagnosing celiac disease. Sensitivity, specificity, and comparative evaluation with the traditional kit. Scand J Gastroenterol 1996;31:759–63
   PubMed Web of Science ®Google Scholar
• Lewis NR, Scott BB. Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther 2006;24:47–54
   PubMed Web of Science ®Google Scholar
• Kapuscinska A, Zalewski T, Chorzelski TP, et al. Disease specificity and dynamics of changes in IgA class anti-endomysial antibodies in celiac disease. J Pediatr Gastroenterol Nutr 1987;6:529–34
   PubMed Web of Science ®Google Scholar
• Cummins A, Thompson F. Sensitivity of anti-endomysial antibody in detecting celiac disease. Gastroenterology 2002;122:246–7
   PubMed Web of Science ®Google Scholar
• Ozgenc F, Aksu G, Aydogdu S, et al. Association between anti-endomysial antibody and total intestinal villous atrophy in children with coeliac disease. J Postgrad Med 2003;49:21–4; discussion 4
   PubMedGoogle Scholar
• Levine A, Bujanover Y, Reif S, et al. Comparison of assays for anti-endomysial and anti-transglutaminase antibodies for diagnosis of pediatric celiac disease. Isr Med Assoc J 2000;2:122–5
   PubMed Web of Science ®Google Scholar
• Dickey W, Hughes DF, McMillan SA. Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one fifth. Scand J Gastroenterol 2000;35:181–3
   PubMed Web of Science ®Google Scholar
• Collin P, Maki M, Kaukinen K. Revival of gliadin antibodies in the diagnostic work-up of celiac disease. J Clin Gastroenterol 2010;44:159–60
   PubMed Web of Science ®Google Scholar
• Rostami K, Kerckhaert J, Tiemessen R, et al. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol 1999;94:888–94
   PubMed Web of Science ®Google Scholar
• Dahele A, Kingstone K, Bode J, et al. Anti-endomysial antibody negative celiac disease: does additional serological testing help? Dig Dis Sci 2001;46:214–21
   PubMed Web of Science ®Google Scholar
• Feighery C, Weir DG, Whelan A, et al. Diagnosis of gluten-sensitive enteropathy: is exclusive reliance on histology appropriate? Eur J Gastroenterol Hepatol 1998;10:919–25
   PubMed Web of Science ®Google Scholar
• Biagi F, Bianchi PI, Campanella J, et al. The prevalence and the causes of minimal intestinal lesions in patients complaining of symptoms suggestive of enteropathy: a follow-up study. J Clin Pathol 2008;61:1116–18
   PubMed Web of Science ®Google Scholar
• Hopper AD, Hadjivassiliou M, Hurlstone DP, et al. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis. Clin Gastroenterol Hepatol 2008;6:314–20
   PubMed Web of Science ®Google Scholar
• Kurppa K, Rasanen T, Collin P, et al. Endomysial antibodies predict celiac disease irrespective of the titers or clinical presentation. World J Gastroenterol 2012;18:2511–16
   PubMed Web of Science ®Google Scholar
• Rostami K, Kerckhaert JP, Tiemessen R, et al. The relationship between anti-endomysium antibodies and villous atrophy in coeliac disease using both monkey and human substrate. Eur J Gastroenterol Hepatol 1999;11:439–42
   PubMed Web of Science ®Google Scholar
• Giersiepen K, Lelgemann M, Stuhldreher N, et al. Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report. J Pediatr Gastroenterol Nutr 2012;54:229–41
   PubMed Web of Science ®Google Scholar
• Di Tola M, Sabbatella L, Anania MC, et al. Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence. Clin Chem Lab Med 2004;42:1092–7
   PubMed Web of Science ®Google Scholar
• Volta U, Granito A, Parisi C, et al. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol 2010;44:186–90
   PubMed Web of Science ®Google Scholar
• Picarelli A, di Tola M, Sabbatella L, et al. Identification of a new coeliac disease subgroup: antiendomysial and anti-transglutaminase antibodies of IgG class in the absence of selective IgA deficiency. J Intern Med 2001;249:181–8
   PubMed Web of Science ®Google Scholar
• Beutner EH, Kumar V, Chorzelski TP, Szaflarska-Czerwionka M. IgG endomysial antibodies in IgA-deficient patient with coeliac disease. Lancet 1989;1:1261–2
   PubMed Web of Science ®Google Scholar
• Sulkanen S, Collin P, Laurila K, Maki M. IgA- and IgG-class antihuman umbilical cord antibody tests in adult coeliac disease. Scand J Gastroenterol 1998;33:251–4
   PubMed Web of Science ®Google Scholar
• Prince HE, Norman GL, Binder WL. Immunoglobulin A (IgA) deficiency and alternative celiac disease-associated antibodies in sera submitted to a reference laboratory for endomysial IgA testing. Clin Diagn Lab Immunol 2000;7:192–6
   PubMedGoogle Scholar
• Korponay-Szabo IR, Kovacs JB, Czinner A, et al. High prevalence of silent celiac disease in preschool children screened with IgA/IgG antiendomysium antibodies. J Pediatr Gastroenterol Nutr 1999;28:26–30
   PubMed Web of Science ®Google Scholar
• Cataldo F, Lio D, Marino V, et al. IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Working Groups on Celiac Disease of SIGEP and Club del Tenue. Gut 2000;47:366–9
   PubMed Web of Science ®Google Scholar
• McGowan KE, Lyon ME, Butzner JD. Celiac disease and IgA deficiency: complications of serological testing approaches encountered in the clinic. Clin Chem 2008;54:1203–9
   PubMed Web of Science ®Google Scholar
• Reeves GE, Squance ML, Duggan AE, et al. Diagnostic accuracy of coeliac serological tests: a prospective study. Eur J Gastroenterol Hepatol 2006;18:493–501
   PubMed Web of Science ®Google Scholar
• Valletta E, Fornaro M, Pecori S, Zanoni G. Selective immunoglobulin A deficiency and celiac disease: let's give serology a chance. J Investig Allergol Clin Immunol 2011;21:242–4
   PubMed Web of Science ®Google Scholar
• Izzi L. Anti-endomysium antibodies detection in the celiac disease screening: indirect immunofluorescence pattern using umbilical cord sections as substrate. ALTEX 1998;15:141–3
   PubMedGoogle Scholar
• Castellino F, Scaglione N, Grosso SB, Sategna-Guidetti C. A novel method for detecting IgA endomysial antibodies by using human umbilical vein endothelial cells. Eur J Gastroenterol Hepatol 2000;12:45–9
   PubMed Web of Science ®Google Scholar
• Murray JA, Herlein J, Mitros F, Goeken JA. Serologic testing for celiac disease in the United States: results of a multilaboratory comparison study. Clin Diagn Lab Immunol 2000;7:584–7
   PubMedGoogle Scholar
• Lasagni D, Ferrari R, Lapini M. Unmasking anti-endomysial antibodies in coeliac subjects positive for anti-smooth muscle antibodies. Acta Paediatr 1999;88:462–4
   PubMed Web of Science ®Google Scholar
• Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3:797–801
   PubMed Web of Science ®Google Scholar
• Dieterich W, Laag E, Schopper H, et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998;115:1317–21
   PubMed Web of Science ®Google Scholar
• Chan AW, Butzner JD, McKenna R, Fritzler MJ. Tissue transglutaminase enzyme-linked immunosorbent assay as a screening test for celiac disease in pediatric patients. Pediatrics 2001;107:1–4
   PubMed Web of Science ®Google Scholar
• Gillett HR, Freeman HJ. Comparison of IgA endomysium antibody and IgA tissue transglutaminase antibody in celiac disease. Can J Gastroenterol 2000;14:668–71
   PubMedGoogle Scholar
• Poddar U, Thapa BR, Nain CK, Singh K. Is tissue transglutaminase autoantibody the best for diagnosing celiac disease in children of developing countries? J Clin Gastroenterol 2008;42:147–51
   PubMed Web of Science ®Google Scholar
• Troncone R, Maurano F, Rossi M, et al. IgA antibodies to tissue transglutaminase: an effective diagnostic test for celiac disease. J Pediatr 1999;134:166–71
   PubMed Web of Science ®Google Scholar
• Vitoria JC, Arrieta A, Arranz C, et al. Antibodies to gliadin, endomysium, and tissue transglutaminase for the diagnosis of celiac disease. J Pediatr Gastroenterol Nutr 1999;29:571–4
   PubMed Web of Science ®Google Scholar
• Carroccio A, Giannitrapani L, Soresi M, et al. Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease. Gut 2001;49:506–11
   PubMed Web of Science ®Google Scholar
• Clemente MG, Musu MP, Frau F, et al. Antitissue transglutaminase antibodies outside celiac disease. J Pediatr Gastroenterol Nutr 2002;34:31–4
   PubMed Web of Science ®Google Scholar
• Koop I, Ilchmann R, Izzi L, et al. Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis. Am J Gastroenterol 2000;95:2009–14
   PubMed Web of Science ®Google Scholar
• Weiss B, Bujanover Y, Avidan B, et al. Positive tissue transglutaminase antibodies with negative endomysial antibodies: low rate of celiac disease. Isr Med Assoc J 2004;6:9–12
   PubMed Web of Science ®Google Scholar
• Burgin-Wolff A, Dahlbom I, Hadziselimovic F, Petersson CJ. Antibodies against human tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease. Scand J Gastroenterol 2002;37:685–91
   PubMed Web of Science ®Google Scholar
• Carroccio A, Vitale G, Di Prima L, et al. Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study. Clin Chem 2002;48:1546–50
   PubMed Web of Science ®Google Scholar
• Fabiani E, Peruzzi E, Mandolesi A, et al. Anti-human versus anti-guinea pig tissue transglutaminase antibodies as the first-level serological screening test for coeliac disease in the general population. Dig Liver Dis 2004;36:671–6
   PubMedGoogle Scholar
• Tonutti E, Visentini D, Bizzaro N, et al. The role of antitissue transglutaminase assay for the diagnosis and monitoring of coeliac disease: a French-Italian multicentre study. J Clin Pathol 2003;56:389–93
   PubMed Web of Science ®Google Scholar
• Wolters V, Vooijs-Moulaert AF, Burger H, et al. Human tissue transglutaminase enzyme linked immunosorbent assay outperforms both the guinea pig based tissue transglutaminase assay and anti-endomysium antibodies when screening for coeliac disease. Eur J Pediatr 2002;161:284–7
   PubMed Web of Science ®Google Scholar
• Wong RC, Wilson RJ, Steele RH, et al. A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. J Clin Pathol 2002;55:488–94
   PubMed Web of Science ®Google Scholar
• Baudon JJ, Johanet C, Absalon YB, et al. Diagnosing celiac disease: a comparison of human tissue transglutaminase antibodies with antigliadin and antiendomysium antibodies. Arch Pediatr Adolesc Med 2004;158:584–8
   PubMedGoogle Scholar
• Collin P, Kaukinen K, Vogelsang H, et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol 2005;17:85–91
   PubMed Web of Science ®Google Scholar
• Tesei N, Sugai E, Vazquez H, et al. Antibodies to human recombinant tissue transglutaminase may detect coeliac disease patients undiagnosed by endomysial antibodies. Aliment Pharmacol Ther 2003;17:1415–23
   PubMed Web of Science ®Google Scholar
• Van Meensel B, Hiele M, Hoffman I, et al. Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease. Clin Chem 2004;50:2125–35
   PubMed Web of Science ®Google Scholar
• Hopper AD, Cross SS, Hurlstone DP, et al. Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ 2007;334:729
   PubMedGoogle Scholar
• Niveloni S, Sugai E, Cabanne A, et al. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease. Clin Chem 2007;53:2186–92
   PubMed Web of Science ®Google Scholar
• Parizade M, Bujanover Y, Weiss B, et al. Performance of serology assays for diagnosing celiac disease in a clinical setting. Clin Vaccine Immunol 2009;16:1576–82
   PubMedGoogle Scholar
• Sugai E, Moreno ML, Hwang HJ, et al. Celiac disease serology in patients with different pretest probabilities: is biopsy avoidable? World J Gastroenterol 2010;16:3144–52
   PubMed Web of Science ®Google Scholar
• Alessio MG, Tonutti E, Brusca I, et al. Correlation between IgA tissue transglutaminase antibody ratio and histological finding in celiac disease. J Pediatr Gastroenterol Nutr 2012;55:44–9
   PubMed Web of Science ®Google Scholar
• Barker CC, Mitton C, Jevon G, Mock T. Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations? Pediatrics 2005;115:1341–6
   PubMed Web of Science ®Google Scholar
• Donaldson MR, Book LS, Leiferman KM, et al. Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease. J Clin Gastroenterol 2008;42:256–60
   PubMed Web of Science ®Google Scholar
• Hill PG, Holmes GK. Coeliac disease: a biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther 2008;27:572–7
   PubMed Web of Science ®Google Scholar
• Mubarak A, Wolters VM, Gerritsen SA, et al. A biopsy is not always necessary to diagnose celiac disease. J Pediatr Gastroenterol Nutr 2011;52:554–7
   PubMed Web of Science ®Google Scholar
• Zanini B, Magni A, Caselani F, et al. High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease. Dig Liver Dis 2012;44:280–5
   PubMedGoogle Scholar
• Mubarak A, Wolters VM, Gmelig-Meyling FH, et al. Tissue transglutaminase levels above 100 U/mL and celiac disease: a prospective study. World J Gastroenterol 2012;18:4399–403
   PubMed Web of Science ®Google Scholar
• Sandstrom O, Rosen A, Lagerqvist C, et al. Transglutaminase IgA antibodies in a celiac disease mass screening and the role of HLA-DQ genotyping and endomysial antibodies in sequential testing. J Pediatr Gastroenterol Nutr 2013;57:472–6
   PubMed Web of Science ®Google Scholar
• Villalta D, Alessio MG, Tampoia M, et al. Diagnostic accuracy of IgA anti-tissue transglutaminase antibody assays in celiac disease patients with selective IgA deficiency. Ann N Y Acad Sci 2007;1109:212–20
   PubMed Web of Science ®Google Scholar
• Dahlbom I, Olsson M, Forooz NK, et al. Immunoglobulin G (IgG) anti-tissue transglutaminase antibodies used as markers for IgA-deficient celiac disease patients. Clin Diagn Lab Immunol 2005;12:254–8
   PubMedGoogle Scholar
• Korponay-Szabo IR, Dahlbom I, Laurila K, et al. Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency. Gut 2003;52:1567–71
   PubMed Web of Science ®Google Scholar
• Baldas V, Tommasini A, Trevisiol C, et al. Development of a novel rapid non-invasive screening test for coeliac disease. Gut 2000;47:628–31
   PubMed Web of Science ®Google Scholar
• Sorell L, Garrote JA, Acevedo B, Arranz E. One-step immunochromatographic assay for screening of coeliac disease. Lancet 2002;359:945–6
   PubMed Web of Science ®Google Scholar
• Nemec G, Ventura A, Stefano M, et al. Looking for celiac disease: diagnostic accuracy of two rapid commercial assays. Am J Gastroenterol 2006;101:1597–600
   PubMed Web of Science ®Google Scholar
• Raivio T, Kaukinen K, Nemes E, et al. Self transglutaminase-based rapid coeliac disease antibody detection by a lateral flow method. Aliment Pharmacol Ther 2006;24:147–54
   PubMed Web of Science ®Google Scholar
• Raivio T, Korponay-Szabo I, Collin P, et al. Performance of a new rapid whole blood coeliac test in adult patients with low prevalence of endomysial antibodies. Dig Liver Dis 2007;39:1057–63
   PubMedGoogle Scholar
• Korponay-Szabo IR, Szabados K, Pusztai J, et al. Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study. BMJ 2007;335:1244–7
   PubMed Web of Science ®Google Scholar
• Alarida K, Harown J, Ahmaida A, et al. Coeliac disease in Libyan children: a screening study based on the rapid determination of anti-transglutaminase antibodies. Dig Liver Dis 2011;43:688–91
   PubMedGoogle Scholar
• Aleanzi M, Demonte AM, Esper C, et al. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides. Clin Chem 2001;47:2023–8
   PubMed Web of Science ®Google Scholar
• Schwertz E, Kahlenberg F, Sack U, et al. Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease. Clin Chem. 2004;50:2370–5
   PubMed Web of Science ®Google Scholar
• Agardh D. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease. Clin Gastroenterol Hepatol 2007;5:1276–81
   PubMed Web of Science ®Google Scholar
• Basso D, Guariso G, Fogar P, et al. Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. Clin Chem 2009;55:150–7
   PubMed Web of Science ®Google Scholar
• Dahle C, Hagman A, Ignatova S, Strom M. Antibodies against deamidated gliadin peptides identify adult coeliac disease patients negative for antibodies against endomysium and tissue transglutaminase. Aliment Pharmacol Ther 2010;32:254–60
   PubMed Web of Science ®Google Scholar
• Jaskowski TD, Donaldson MR, Hull CM, et al. Novel screening assay performance in pediatric celiac disease and adult dermatitis herpetiformis. J Pediatr Gastroenterol Nutr 2010;51:19–23
   PubMed Web of Science ®Google Scholar
• Naiyer AJ, Hernandez L, Ciaccio EJ, et al. Comparison of commercially available serologic kits for the detection of celiac disease. J Clin Gastroenterol 2009;43:225–32
   PubMed Web of Science ®Google Scholar
• Olen O, Gudjonsdottir AH, Browaldh L, et al. Antibodies against deamidated gliadin peptides and tissue transglutaminase for diagnosis of pediatric celiac disease. J Pediatr Gastroenterol Nutr 2012;55:695–700
   PubMed Web of Science ®Google Scholar
• Prause C, Richter T, Koletzko S, et al. New developments in serodiagnosis of childhood celiac disease: assay of antibodies against deamidated gliadin. Ann N Y Acad Sci 2009;1173:28–35
   PubMed Web of Science ®Google Scholar
• Sakly W, Mankai A, Ghdess A, et al. Performance of anti-deamidated gliadin peptides antibodies in celiac disease diagnosis. Clin Res Hepatol Gastroenterol 2012;36:598–603
   PubMed Web of Science ®Google Scholar
• Villalta D, Tonutti E, Prause C, et al. IgG antibodies against deamidated gliadin peptides for diagnosis of celiac disease in patients with IgA deficiency. Clin Chem 2010;56:464–8
   PubMed Web of Science ®Google Scholar
• Health Quality Ontario. Clinical utility of serologic testing for celiac disease in Ontario: an evidence-based analysis. Ont Health Technol Assess Ser 2010;10:1–111
   Google Scholar
• Lewis NR, Scott BB. Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 2010;31:73–81
   PubMed Web of Science ®Google Scholar
• Monzani A, Rapa A, Fonio P, et al. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease. J Pediatr Gastroenterol Nutr 2011;53:55–60
   PubMed Web of Science ®Google Scholar
• Sugai E, Hwang HJ, Vazquez H, et al. New serology assays can detect gluten sensitivity among enteropathy patients seronegative for anti-tissue transglutaminase. Clin Chem 2010;56:661–5
   PubMed Web of Science ®Google Scholar
• Mozo L, Gomez J, Escanlar E, et al. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients. J Pediatr Gastroenterol Nutr 2012;55:50–5
   PubMed Web of Science ®Google Scholar
• Amarri S, Alvisi P, De Giorgio R, et al. Antibodies to deamidated gliadin peptides: an accurate predictor of coeliac disease in infancy. J Clin Immunol 2013;33:1027–30
   PubMed Web of Science ®Google Scholar
• Liu E, Li M, Emery L, et al. Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease. J Pediatr Gastroenterol Nutr 2007;45:293–300
   PubMed Web of Science ®Google Scholar
• Mubarak A, Gmelig-Meyling FH, Wolters VM, et al. Immunoglobulin G antibodies against deamidated-gliadin-peptides outperform anti-endomysium and tissue transglutaminase antibodies in children <2 years age. Apmis 2011;119:894–900
   PubMed Web of Science ®Google Scholar
• Barbato M, Maiella G, Di Camillo C, et al. The anti-deamidated gliadin peptide antibodies unmask celiac disease in small children with chronic diarrhoea. Dig Liver Dis 2011;43:465–9
   PubMedGoogle Scholar
• Benkebil F, Combescure C, Anghel SI, et al. Diagnostic accuracy of a new point-of-care screening assay for celiac disease. World J Gastroenterol 2013;19:5111–17
   PubMed Web of Science ®Google Scholar
• Bienvenu F, Besson Duvanel C, Seignovert C, et al. Evaluation of a point-of-care test based on deamidated gliadin peptides for celiac disease screening in a large pediatric population. Eur J Gastroenterol Hepatol 2012;24:1418–23
   PubMed Web of Science ®Google Scholar
• Nachman F, Sugai E, Vazquez H, et al. Serological tests for celiac disease as indicators of long-term compliance with the gluten-free diet. Eur J Gastroenterol Hepatol 2011;23:473–80
   PubMed Web of Science ®Google Scholar
• Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999;93:190–7
   PubMed Web of Science ®Google Scholar
• Estey MP, Cohen AH, Colantonio DA, et al. CLSI-based transference of the CALIPER database of pediatric reference intervals from Abbott to Beckman, Ortho, Roche and Siemens Clinical Chemistry Assays: direct validation using reference samples from the CALIPER cohort. Clin Biochem 2013;46:1197–219
   PubMed Web of Science ®Google Scholar
• Fernandez E, Blanco C, Garcia S, et al. Use of low concentrations of human IgA anti-tissue transglutaminase to rule out selective IgA deficiency in patients with suspected celiac disease. Clin Chem 2005;51:1014–16
   PubMed Web of Science ®Google Scholar
• Lowbeer C, Wallinder H. Undetectable anti-tissue transglutaminase IgA antibody measured with EliA Celikey indicates selective IgA deficiency. Clin Chim Acta 2010;411:612
   PubMed Web of Science ®Google Scholar
• Sinclair D, Saas M, Turk A, et al. Do we need to measure total serum IgA to exclude IgA deficiency in coeliac disease? J Clin Pathol 2006;59:736–9
   PubMed Web of Science ®Google Scholar
• Dorn SD, Matchar DB. Cost-effectiveness analysis of strategies for diagnosing celiac disease. Dig Dis Sci 2008;53:680–8
   PubMed Web of Science ®Google Scholar
• Lock RJ, Pitcher MC, Unsworth DJ. IgA anti-tissue transglutaminase as a diagnostic marker of gluten sensitive enteropathy. J Clin Pathol 1999;52:274–7
   PubMed Web of Science ®Google Scholar
• Seah PP, Fry L, Hoffbrand AV, Holborow EJ. Tissue antibodies in dermatitis herpetiformis and adult coeliac disease. Lancet 1971;1:834–6
   PubMed Web of Science ®Google Scholar
• Rizzetto M, Doniach D. Types of ‘reticulin' antibodies detected in human sera by immunofluorescence. J Clin Pathol 1973;26:841–51
   PubMed Web of Science ®Google Scholar
• Eade OE, Lloyd RS, Lang C, Wright R. IgA and IgG reticulin antibodies in coeliac and non-coeliac patients. Gut 1977;18:991–3
   PubMed Web of Science ®Google Scholar
• Seah PP, Fry L, Holborow EJ, et al. Antireticulin antibody: incidence and diagnostic significance. Gut 1973;14:311–15
   PubMed Web of Science ®Google Scholar
• Maki M. The humoral immune system in coeliac disease. Bailliere's Clin Gastroenterol 1995;9:231–49
   PubMed Web of Science ®Google Scholar
• Hallstrom O. Comparison of IgA-class reticulin and endomysium antibodies in coeliac disease and dermatitis herpetiformis. Gut 1989;30:1225–32
   PubMed Web of Science ®Google Scholar
• Nandiwada SL, Tebo AE. Testing for antireticulin antibodies in patients with celiac disease is obsolete: a review of recommendations for serologic screening and the literature. Clin Vaccine Immunol 2013;20:447–51
   PubMed Web of Science ®Google Scholar
• Bai JC, Fried M, Corazza GR, et al. World Gastroenterology Organisation global guidelines on celiac disease. J Clin Gastroenterol 2013;47:121–6
   PubMed Web of Science ®Google Scholar
• Troncone R, Ferguson A. Anti-gliadin antibodies. J Pediatr Gastroenterol Nutr 1991;12:150–8
   PubMed Web of Science ®Google Scholar
• Unsworth DJ, Kieffer M, Holborow EJ, et al. IgA anti-gliadin antibodies in coeliac disease. Clin Exp Immunol 1981;46:286–93
   PubMed Web of Science ®Google Scholar
• Unsworth DJ, Manuel PD, Walker-Smith JA, et al. New immunofluorescent blood test for gluten sensitivity. Arch Dis Child 1981;56:864–8
   PubMed Web of Science ®Google Scholar
• Ascher H, Lanner A, Kristiansson B. A new laboratory kit for anti-gliadin IgA at diagnosis and follow-up of childhood celiac disease. J Pediatr Gastroenterol Nutr 1990;10:443–50
   PubMed Web of Science ®Google Scholar
• Gonczi J, Skerritt JH, Mitchell JD. A reliable screening test for coeliac disease: enzyme-linked immunosorbent assay to detect anti-gliadin antibodies in serum. Aust N Z J Med 1991;21:723–31
   PubMedGoogle Scholar
• Leffler DA, Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol 2010;105:2520–4
   PubMed Web of Science ®Google Scholar
• van der Windt DA, Jellema P, Mulder CJ, et al. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA 2010;303:1738–46
   PubMed Web of Science ®Google Scholar
• Benson BC, Mulder CJ, Laczek JT. Anti-gliadin antibodies identify celiac patients overlooked by tissue transglutaminase antibodies. Hawaii J Med Public Health 2013;72:14–17
   PubMedGoogle Scholar
• Moore JK, West SR, Robins G. Advances in celiac disease. Curr Opin Gastroenterol 2011;27:112–18
   PubMed Web of Science ®Google Scholar
• Matthias T, Pfeiffer S, Selmi C, Eric Gershwin M. Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope. Clin Rev Allergy Immunol 2010;38:298–301
   PubMed Web of Science ®Google Scholar
• Lytton SD, Antiga E, Pfeiffer S, et al. Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease–dermatitis herpetiformis. Clin Chim Acta 2013;415:346–9
   PubMed Web of Science ®Google Scholar
• Barak M, Rozenberg O, Froom P, et al. Challenging our serological algorithm for celiac disease (CD) diagnosis by the ESPGHAN guidelines. Clin Chem Lab Med 2013;51:e257–9
   PubMed Web of Science ®Google Scholar
• Carroccio A, Brusca I, Iacono G, et al. Anti-actin antibodies in celiac disease: correlation with intestinal mucosa damage and comparison of ELISA with the immunofluorescence assay. Clin Chem 2005;51:917–20
   PubMed Web of Science ®Google Scholar
• Duerksen DR, Wilhelm-Boyles C, Veitch R, et al. A comparison of antibody testing, permeability testing, and zonulin levels with small-bowel biopsy in celiac disease patients on a gluten-free diet. Dig Dis Sci 2010;55:1026–31
   PubMed Web of Science ®Google Scholar
• Fabbro E, Rubert L, Quaglia S, et al. Uselessness of anti-actin antibody in celiac disease screening. Clin Chim Acta 2008;390:134–7
   PubMed Web of Science ®Google Scholar
• Carroccio A, Brusca I, Iacono G, et al. IgA anti-actin antibodies ELISA in coeliac disease: a multicentre study. Dig Liver Dis 2007;39:818–23
   PubMedGoogle Scholar
• Achour A, Thabet Y, Sakly W, et al. IgA anti-actin antibodies in celiac disease. Gastroenterol Clin Biol 2010;34:483–7
   PubMedGoogle Scholar
• Schirru E, Danjou F, Cicotto L, et al. Anti-actin IgA antibodies identify celiac disease patients with a Marsh 3 Intestinal damage among subjects with moderate anti-TG2 levels. Biomed Res Int 2013;2013:630463
   PubMed Web of Science ®Google Scholar
• Tack GJ, van Wanrooij RL, Von Blomberg BM, et al. Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing–a cohort study. BMC Gastroenterol 2012;12:159
   PubMed Web of Science ®Google Scholar
• Manavalan JS, Hernandez L, Shah JG, et al. Serum cytokine elevations in celiac disease: association with disease presentation. Hum Immunol 2010;71:50–7
   PubMed Web of Science ®Google Scholar
• McCluskey J, Kanaan C, Diviney M. Nomenclature and serology of HLA class I and class II alleles. Curr Protoc Immunol 2003;52:1S:A.1S.1–A.1S.8
   Google Scholar
• Nunes E, Heslop H, Fernandez-Vina M, et al. Definitions of histocompatibility typing terms. Blood 2011;118:e180–3
   Web of Science ®Google Scholar
• Nepom GT, Erlich H. MHC class-II molecules and autoimmunity. Annu Rev Immunol 1991;9:493–525
   PubMed Web of Science ®Google Scholar
• Greco L, Romino R, Coto I, et al. The first large population based twin study of coeliac disease. Gut 2002;50:624–8
   PubMed Web of Science ®Google Scholar
• Hervonen K, Karell K, Holopainen P, et al. Concordance of dermatitis herpetiformis and celiac disease in monozygous twins. J Invest Dermatol 2000;115:990–3
   PubMed Web of Science ®Google Scholar
• Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003;163:286–92
   PubMed Web of Science ®Google Scholar
• Srivastava A, Yachha SK, Mathias A, et al. Prevalence, human leukocyte antigen typing and strategy for screening among Asian first-degree relatives of children with celiac disease. J Gastroenterol Hepatol 2010;25:319–24
   PubMed Web of Science ®Google Scholar
• Babron MC, Nilsson S, Adamovic S, et al. Meta and pooled analysis of European coeliac disease data. Eur J Hum Genet 2003;11:828–34
   PubMed Web of Science ®Google Scholar
• Garner CP, Ding YC, Steele L, et al. Genome-wide linkage analysis of 160 North American families with celiac disease. Genes Immun 2007;8:108–14
   PubMed Web of Science ®Google Scholar
• Beni V, Zewdu T, Joda H, et al. Gold nanoparticle fluorescent molecular beacon for low-resolution DQ2 gene HLA typing. Anal Bioanal Chem 2012;402:1001–9
   PubMed Web of Science ®Google Scholar
• Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol 2000;18:53–81
   PubMed Web of Science ®Google Scholar
• Vidales MC, Zubillaga P, Zubillaga I, Alfonso-Sanchez MA. Allele and haplotype frequencies for HLA class II (DQA1 and DQB1) loci in patients with celiac disease from Spain. Hum Immunol 2004;65:352–8
   PubMed Web of Science ®Google Scholar
• Anderson RP, Henry MJ, Taylor R, et al. A novel serogenetic approach determines the community prevalence of celiac disease and informs improved diagnostic pathways. BMC Med 2013;11:188
   PubMed Web of Science ®Google Scholar
• Parada A, Araya M, Perez-Bravo F, et al. Amerindian mtDNA haplogroups and celiac disease risk HLA haplotypes in mixed-blood Latin American patients. J Pediatr Gastroenterol Nutr 2011;53:429–34
   PubMed Web of Science ®Google Scholar
• Little AM. An overview of HLA typing for hematopoietic stem cell transplantation. Methods Mol Med 2007;134:35–49
   PubMedGoogle Scholar
• Profaizer T, Eckels D, Delgado JC. Celiac disease and HLA typing using real-time PCR with melting curve analysis. Tissue Antigens 2011;78:31–7
   PubMedGoogle Scholar
• Buyse I, Decorte R, Baens M, et al. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens 1993;41:1–14
   PubMed Web of Science ®Google Scholar
• Joda H, Beni V, Curnane D, et al. Low-medium resolution HLA-DQ2/DQ8 typing for coeliac disease predisposition analysis by colorimetric assay. Anal Bioanal Chem 2012;403:807–19
   PubMed Web of Science ®Google Scholar
• Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225–35
   PubMed Web of Science ®Google Scholar
• Megiorni F, Mora B, Bonamico M, et al. A rapid and sensitive method to detect specific human lymphocyte antigen (HLA) class II alleles associated with celiac disease. Clin Chem Lab Med 2008;46:193–6
   PubMed Web of Science ®Google Scholar
• Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993;41:119–34
   PubMed Web of Science ®Google Scholar
• Lavant EH, Carlson JA. A new automated human leukocyte antigen genotyping strategy to identify DR-DQ risk alleles for celiac disease and type 1 diabetes mellitus. Clin Chem Lab Med 2009;47:1489–95
   PubMed Web of Science ®Google Scholar
• Reinton N, Helgheim A, Shegarfi H, Moghaddam A. A one-step real-time PCR assay for detection of DQA1*05, DQB1*02 and DQB1*0302 to aid diagnosis of celiac disease. J Immunol Methods 2006;316:125–32
   PubMed Web of Science ®Google Scholar
• Lavant EH, Agardh DJ, Nilsson A, Carlson JA. A new PCR-SSP method for HLA DR-DQ risk assessment for celiac disease. Clin Chim Acta 2011;412:782–4
   PubMed Web of Science ®Google Scholar
• Wallace AJ. SSCP/heteroduplex analysis. Methods Mol Biol 2002;187:151–63
   PubMedGoogle Scholar
• van Beek EM, Roelandse-Koop EA, Vijzelaar R, et al. A multiplex assay to rapidly exclude HLA-DQ2.5 and HLA-DQ8 expression in patients at risk for celiac disease. Clin Chem Lab Med 2013;51:1191–8
   PubMed Web of Science ®Google Scholar
• Best DH, Lyon E, Roberts KA, et al. Quick Guide to Molecular Diagnostics. Washington, DC: American Association for Clinical Chemistry; 2013
   Google Scholar
• de Bakker PI, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006;38:1166–72
   PubMed Web of Science ®Google Scholar
• Monsuur AJ, de Bakker PI, Zhernakova A, et al. Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms. PLoS One 2008;3:e2270
   PubMed Web of Science ®Google Scholar
• Husby S, Murray JA. New aspects of the diagnosis of celiac disease in children, adolescents, and adults. Mayo Clin Proc 2013;88:540–3
   PubMed Web of Science ®Google Scholar
• Pietzak MM, Schofield TC, McGinniss MJ, Nakamura RM. Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles. Clin Gastroenterol Hepatol 2009;7:966–71
   PubMed Web of Science ®Google Scholar
• Megiorni F, Mora B, Bonamico M, et al. HLA-DQ and risk gradient for celiac disease. Hum Immunol 2009;70:55–9
   PubMed Web of Science ®Google Scholar
• Piccini B, Vascotto M, Serracca L, et al. HLA-DQ typing in the diagnostic algorithm of celiac disease. Rev Esp Enferm Dig 2012;104:248–54
   PubMed Web of Science ®Google Scholar
• Chang M, Green PH. Genetic testing before serologic screening in relatives of patients with celiac disease as a cost containment method. J Clin Gastroenterol 2009;43:43–50
   PubMed Web of Science ®Google Scholar
• Bjorck S, Brundin C, Lorinc E, et al. Screening detects a high proportion of celiac disease in young HLA-genotyped children. J Pediatr Gastroenterol Nutr 2010;50:49–53
   PubMed Web of Science ®Google Scholar
• Beltran L, Koenig M, Egner W, et al. High-titre circulating TTG2 antibodies predict small bowel villous atrophy, but decision cut-off limits must be locally validated. Clin Exp Immunol 2014;176:190–8
   PubMed Web of Science ®Google Scholar
• Vermeersch P, Geboes K, Marien G, et al. Defining thresholds of antibody levels improves diagnosis of celiac disease. Clin Gastroenterol Hepatol 2013;11:398–403; quiz e32
   PubMed Web of Science ®Google Scholar
• Hogberg L, Stenhammar L. Celiac disease: pediatric celiac disease–is a diagnostic biopsy necessary? Nat Rev Gastroenterol Hepatol 2012;9:127–8
   PubMed Web of Science ®Google Scholar
• Klapp G, Masip E, Bolonio M, et al. Celiac disease: the new proposed ESPGHAN diagnostic criteria do work well in a selected population. J Pediatr Gastroenterol Nutr 2013;56:251–6
   PubMed Web of Science ®Google Scholar
• Guandalini S, Newland C. Can we really skip the biopsy in diagnosing symptomatic children with celiac disease. J Pediatr Gastroenterol Nutr 2013;57:e24
   PubMed Web of Science ®Google Scholar
• Nevoral J, Kotalova R, Hradsky O, et al. Symptom positivity is essential for omitting biopsy in children with suspected celiac disease according to the new ESPGHAN guidelines. Eur J Pediatr 2013 Nov 15
   Google Scholar
• Burgin-Wolff A, Mauro B, Faruk H. Intestinal biopsy is not always required to diagnose celiac disease: a retrospective analysis of combined antibody tests. BMC Gastroenterol 2013;13:19
   PubMed Web of Science ®Google Scholar
• Clouzeau-Girard H, Rebouissoux L, Taupin JL, et al. HLA-DQ genotyping combined with serological markers for the diagnosis of celiac disease: is intestinal biopsy still mandatory? J Pediatr Gastroenterol Nutr 2011;52:729–33
   PubMed Web of Science ®Google Scholar
• Vecsei A, Arenz T, Heilig G, et al. Influence of age and genetic risk on anti-tissue transglutaminase IgA titers. J Pediatr Gastroenterol Nutr 2009;48:544–9
   PubMed Web of Science ®Google Scholar